Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Other Non-Current Liabilities (2023 - 2025)

PAVmed (PAVM) has 3 years of Other Non-Current Liabilities data on record, last reported at $6.6 million in Q1 2025.

  • For Q1 2025, Other Non-Current Liabilities changed N/A year-over-year to $6.6 million; the TTM value through Mar 2025 reached $6.6 million, changed N/A, while the annual FY2024 figure was $29.1 million, 34.16% down from the prior year.
  • Other Non-Current Liabilities reached $6.6 million in Q1 2025 per PAVM's latest filing, down from $29.1 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $44.2 million in Q4 2023 and bottomed at $260000.0 in Q2 2023.
  • Average Other Non-Current Liabilities over 3 years is $16.1 million, with a median of $6.6 million recorded in 2025.
  • The widest YoY moves for Other Non-Current Liabilities: up 34.16% in 2024, down 34.16% in 2024.
  • A 3-year view of Other Non-Current Liabilities shows it stood at $44.2 million in 2023, then crashed by 34.16% to $29.1 million in 2024, then plummeted by 77.32% to $6.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $6.6 million in Q1 2025, $29.1 million in Q4 2024, and $44.2 million in Q4 2023.